Literature DB >> 12740789

MELD score predicts 1-year patient survival post-orthotopic liver transplantation.

Sammy Saab1, Victor Wang, Ayman B Ibrahim, Francisco Durazo, Steven Han, Douglas G Farmer, Hasan Yersiz, Marcia Morrisey, Leonard I Goldstein, R Mark Ghobrial, Ronald W Busuttil.   

Abstract

The Model for End-Stage Liver Disease (MELD) is an important predictor in patients awaiting orthotopic liver transplantation (OLT). However, the model's association with posttransplant patient survival is unclear. We studied 1-year patient survival in 404 adult patients who underwent OLT at the University of California Los Angeles. The hazard rates of patient survival according to the MELD strata and United Network for Organ Sharing (UNOS) statuses were assessed by Proportional Hazard Cox regression analysis. The difference in survival for MELD strata and UNOS status were compared using the Cox model. There was a significant difference in 1-year patient (P =.0006) survival using different MELD strata, whereas there was a trend according to UNOS status (P =.051). Increased rate of death was observed in recipients of OLT with higher MELD scores (> 36, hazard ratio 3.9; 95% CI 1.55, 10.27) and more urgent UNOS status (2A; hazard ratio, 1.99; 95% CI 1.07, 3.7). The MELD stratum is better associated with 1-year patient survival in liver transplant recipients than UNOS statuses. Patient survival was worse with higher MELD scores.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740789     DOI: 10.1053/jlts.2003.50090

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  33 in total

Review 1.  Liver resection and transplantation in hepatocellular carcinoma.

Authors:  J Belghiti; D Fuks
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

2.  Preoperative assessment of the risk factors that help to predict the prognosis after living donor liver transplantation.

Authors:  Ryuichi Yoshida; Takayuki Iwamoto; Takahito Yagi; Daisuke Sato; Yuzo Umeda; Kenji Mizuno; Susumu Shinoura; Hiroyoshi Matsukawa; Hiroaki Matsuda; Hiroshi Sadamori; Noriaki Tanaka
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

3.  A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation.

Authors:  Toru Ikegami; Ken Shirabe; Shohei Yoshiya; Tomoharu Yoshizumi; Yo-Ichi Yamashita; Norifumi Harimoto; Takeo Toshima; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-02-23       Impact factor: 2.549

4.  Geographic inequity in access to livers for transplantation.

Authors:  Heidi Yeh; Elizabeth Smoot; David A Schoenfeld; James F Markmann
Journal:  Transplantation       Date:  2011-02-27       Impact factor: 4.939

5.  Model for end-stage liver disease score predicts complications after liver transplantation.

Authors:  Hans-Christian Pommergaard; Thomas Røjkjær Daugaard; Andreas Arendtsen Rostved; Nicolai Aagaard Schultz; Jens Hillingsø; Paul Suno Krohn; Allan Rasmussen
Journal:  Langenbecks Arch Surg       Date:  2020-11-02       Impact factor: 3.445

6.  Physician predictions of graft survival following liver transplantation.

Authors:  Nathan R Hoot; Irene D Feurer; Mary T Austin; Michael K Porayko; J Kelly Wright; Nancy M Lorenzi; C Wright Pinson; Dominik Aronsky
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

7.  Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.

Authors:  Pratima Sharma; Nathan P Goodrich; Min Zhang; Mary K Guidinger; Douglas E Schaubel; Robert M Merion
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

8.  Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.

Authors:  Ramanathan M Seshadri; Siddesh Besur; David J Niemeyer; Megan Templin; Iain H McKillop; Ryan Z Swan; John B Martinie; Mark W Russo; David A Iannitti
Journal:  HPB (Oxford)       Date:  2014-06-25       Impact factor: 3.647

9.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

Review 10.  Liver Transplantation for Cholestatic Liver Diseases in Adults.

Authors:  Vandana Khungar; David Seth Goldberg
Journal:  Clin Liver Dis       Date:  2015-10-23       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.